Similarly, its expression was identified to be up-regulated (∼6.5-fold) in tamoxifen-resistant versus tamoxifen-sensitive MCF-7 and T47D breast cancer cell lines; and as expected, knockdown of CCAT2 facilitated apoptosis and necrosis in tamoxifen-resistant cells [16]. The gene discussed is CCAT2; the disease is breast carcinoma.